FDA Wants to Ban Another Natural Supplement with Success in Treating Symptoms of COVID-19 – Vaccine Impact

The FDA could be preparing to unleash an anti-supplement policy as early as next year that could eliminate tens of thousands of products from the market—in the middle of a pandemic. Action Alert!

N-acetyl-L-cysteine (NAC) has been on the market as a supplement for decades—why is the FDA attacking it now? A few weeks ago, we told you about the FDA’s recent actions threatening NAC supplements—products which the FDA has allowed on the market for decades. The question is, why now, after all these years, is the FDA doing this?

So, why is the FDA threatening NAC now, during a pandemic when a new FDA commissioner hasn’t even been appointed? For starters, a drug company is investigating NAC as a treatment for a rare genetic disorder that damages the myelin sheath, which insulates nerve cells in the brain. The Phase 1 trial was completed in March 2020.

So, why is the FDA threatening NAC now, during a pandemic when a new FDA commissioner hasn’t even been appointed? For starters, a drug company is investigating NAC as a treatment for a rare genetic disorder that damages the myelin sheath, which insulates nerve cells in the brain. The Phase 1 trial was completed in March 2020.

Given these facts, it seems reasonable to assume that the FDA is setting the stage for a new NAC drug to come to market by removing the competition from much cheaper NAC supplements.

FDA Wants to Ban Another Natural Supplement with Success in Treating Symptoms of COVID-19 – Vaccine Impact